a jump in shares of French pharma giant Sanofi added to the positive mood created by expectations of more moves by central banks to stir growth.
France's CAC 40 outperformed its peers with a 1.2% rise, helped by a 4.5% jump in Sanofi after the company appointed Swiss rival Novartis' executive Paul Hudson as its new boss.
The stock was on track to post its best day in more than seven months, helping the healthcare sector rise 0.5%.
"Hudson's immediate challenges will be working with the new CFO to improve cost efficiency in the business," analysts at Liberum Capital said in a note. "As an external, and non-French hire Hudson will be seen as a step in the right direction."
Investors have largely favoured defensive sectors such as utilities and healthcare in a week that has seen stock markets globally gain despite uncertainties over trade and monetary policy.